223 related articles for article (PubMed ID: 29599201)
1. The chromatin-remodeling factor
Heshmati Y; Türköz G; Harisankar A; Kharazi S; Boström J; Dolatabadi EK; Krstic A; Chang D; Månsson R; Altun M; Qian H; Walfridsson J
Haematologica; 2018 Jul; 103(7):1169-1181. PubMed ID: 29599201
[TBL] [Abstract][Full Text] [Related]
2. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
3. Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation.
Sperlazza J; Rahmani M; Beckta J; Aust M; Hawkins E; Wang SZ; Zu Zhu S; Podder S; Dumur C; Archer K; Grant S; Ginder GD
Blood; 2015 Sep; 126(12):1462-72. PubMed ID: 26265695
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
5. shRNA screening identifies JMJD1C as being required for leukemia maintenance.
Sroczynska P; Cruickshank VA; Bukowski JP; Miyagi S; Bagger FO; Walfridsson J; Schuster MB; Porse B; Helin K
Blood; 2014 Mar; 123(12):1870-82. PubMed ID: 24501218
[TBL] [Abstract][Full Text] [Related]
6. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
7. Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
Cui P; Zhang Y; Cui M; Li Z; Ma G; Wang R; Wang N; Huang S; Gao J
Leuk Res; 2018 Feb; 65():49-54. PubMed ID: 29306107
[TBL] [Abstract][Full Text] [Related]
8. RNAi screens identify CHD4 as an essential gene in breast cancer growth.
D'Alesio C; Punzi S; Cicalese A; Fornasari L; Furia L; Riva L; Carugo A; Curigliano G; Criscitiello C; Pruneri G; Pelicci PG; Faretta M; Bossi D; Lanfrancone L
Oncotarget; 2016 Dec; 7(49):80901-80915. PubMed ID: 27779108
[TBL] [Abstract][Full Text] [Related]
9. MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.
Biswas M; Chatterjee SS; Boila LD; Chakraborty S; Banerjee D; Sengupta A
FASEB J; 2019 Apr; 33(4):5268-5286. PubMed ID: 30668141
[TBL] [Abstract][Full Text] [Related]
10. Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Böhm M; Wachtel M; Marques JG; Streiff N; Laubscher D; Nanni P; Mamchaoui K; Santoro R; Schäfer BW
J Clin Invest; 2016 Nov; 126(11):4237-4249. PubMed ID: 27760049
[TBL] [Abstract][Full Text] [Related]
11. Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair.
Qi W; Chen H; Xiao T; Wang R; Li T; Han L; Zeng X
Mutagenesis; 2016 Mar; 31(2):193-203. PubMed ID: 26546801
[TBL] [Abstract][Full Text] [Related]
12. Structural maintenance of chromosomes 4 is required for leukemia stem cell maintenance in MLL-AF9 induced acute myeloid leukemia.
Peng L; Tang Y; Zhang Y; Guo S; Peng L; Ye L; Wang Y; Jiang Y
Leuk Lymphoma; 2018 Oct; 59(10):2423-2430. PubMed ID: 29043883
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
[TBL] [Abstract][Full Text] [Related]
14. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
Jafek JL; Shakya A; Tai PY; Ibarra A; Kim H; Maddox J; Chumley J; Spangrude GJ; Miles RR; Kelley TW; Tantin D
Exp Hematol; 2019 Aug; 76():38-48.e2. PubMed ID: 31295506
[TBL] [Abstract][Full Text] [Related]
16. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
[TBL] [Abstract][Full Text] [Related]
17. In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling.
Miller PG; Al-Shahrour F; Hartwell KA; Chu LP; Järås M; Puram RV; Puissant A; Callahan KP; Ashton J; McConkey ME; Poveromo LP; Cowley GS; Kharas MG; Labelle M; Shterental S; Fujisaki J; Silberstein L; Alexe G; Al-Hajj MA; Shelton CA; Armstrong SA; Root DE; Scadden DT; Hynes RO; Mukherjee S; Stegmaier K; Jordan CT; Ebert BL
Cancer Cell; 2013 Jul; 24(1):45-58. PubMed ID: 23770013
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
[TBL] [Abstract][Full Text] [Related]
19. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.
Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J
Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946
[TBL] [Abstract][Full Text] [Related]
20. Leukaemia cell of origin identified by chromatin landscape of bulk tumour cells.
George J; Uyar A; Young K; Kuffler L; Waldron-Francis K; Marquez E; Ucar D; Trowbridge JJ
Nat Commun; 2016 Jul; 7():12166. PubMed ID: 27397025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]